SCHEMBL21980348

SCHEMBL21980348

Cc1cc(Nc2ccccc2)nc(-c2cccc(Cl)c2)n1

nearest known ligand 0.85

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 15/20 0.85
ABCC1 P33527 7/20 0.85
ABCB1 P08183 6/20 0.85
MEN1 O00255 4/20 0.66
KMT2A Q03164 4/20 0.66
NPC1 O15118 1/20 0.66
GBA1 P04062 1/20 0.66
RAB9A P51151 1/20 0.66
KDM4E B2RXH2 2/20 0.56
MAPT P10636 2/20 0.56
MAPK1 P28482 2/20 0.56
NPSR1 Q6W5P4 2/20 0.56
HTT P42858 1/20 0.56
HSD17B10 Q99714 1/20 0.56
LMNA P02545 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21977560 0.87 ABCG2 (1.00) ABCG2ABCC1ABCB1MEN1KMT2A
SCHEMBL16392215 0.83 ABCG2 (0.61) ABCG2ABCC1ABCB1MEN1KMT2A
SCHEMBL390297 0.82 ABCG2 (0.62) ABCG2ABCC1ABCB1MEN1KMT2A
SCHEMBL391608 0.79 ABCG2 (0.57) ABCG2ABCC1ABCB1MEN1KMT2A
SCHEMBL21979438 0.78 ABCG2 (0.82) ABCG2ABCC1ABCB1MEN1KMT2A
SCHEMBL391607 0.78 ABCG2 (0.56) ABCG2ABCC1ABCB1MEN1KMT2A
SCHEMBL390057 0.77 ABCG2 (0.80) ABCG2ABCC1ABCB1MEN1KMT2A
SCHEMBL5487020 0.76 ABCG2 (0.69) ABCG2ABCC1ABCB1MEN1KMT2A
SCHEMBL14987959 0.76 ABCG2 (0.72) ABCG2ABCC1ABCB1MEN1KMT2A
SCHEMBL16682869 0.76 LMNA (0.71) ABCG2ABCC1ABCB1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3019480-B1 2,4- OR 4,6-DIAMINOPYRIMIDINE COMPOUNDS AS IDH2 MUTANTS INHIBITORS FOR THE TREATMENT OF CANCER AGIOS PHARMACEUTICALS INC (US) 2020-05-06 EP disclosed